Table 1 Randomized controlled trials on the use of corticosteroid for the prevention of pancreatic injury after ERCP
From: Meta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitis
Author and publication year | Setting | Jadad score | Sample size | Type of corticosteroid administration | Dosage (mg) | Duration |
|---|---|---|---|---|---|---|
Budzynska, 1997 | Poland single centre | 1 | 184 | Prednisone, orally | 40 | 15 hours and 3 hours before ERCP |
Dumot, 1998 | United States multicentre | 4 | 255 | Methylprednisolone, intravenous bolus | 125 | 15 to 30 minutes before ERCP |
De Palma, 1999 | Italy single centre | 5 | 529 | Hydrocortisone, intravenous infusion | 100 | Immediately before ERCP |
Budzynska, 2001 | Poland single centre | 2 | 201 | Prednisone, orally | 40 | 15 hours and 3 hours before ERCP |
Manolakopoulos, 2002 | Greece multicentre | 5 | 228 | Hydrocortisone, intravenous infusion | 100 | 30 minutes before ERCP |
Sherman, 2003 | United States multicentre | 4 | 1115 | Prednisone, orally | 40 | 15 hours and 3 hours before ERCP |
Kwanngern, 2005 | Thailand single centre | 4 | 120 | Hydrocortisone, intravenous infusion | 100 | 1 hour before ERCP |